中东和非洲呼吸诊断市场 – 行业趋势和 2030 年预测

中东和非洲呼吸诊断市场分析和规模

中东和非洲地区受到慢性病负担的严重影响，这增加了呼吸诊断的采用。根据国际糖尿病联合会 (IDF) 2021 年的报告，IDF 非洲地区有 2400 万成年人 (20-79 岁) 患有糖尿病。糖尿病负担的加重正在导致市场大幅扩张。呼吸系统疾病发病率的上升引起了人们对准确疾病诊断的极大关注，从而促进了呼吸诊断市场的增长。

Data Bridge Market Research 分析了 2023-2030 年预测期内呼吸诊断市场的增长率。在上述预测期内，呼吸诊断市场的预期复合年增长率趋于 9.8% 左右。2022 年市场价值为 14.417 亿美元，到 2030 年将增长至 30.4575 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

中东和非洲呼吸诊断市场范围和细分

Market Definition

Respiratory diagnostics are the type of medical products and technologies that are widely used to diagnose the respiratory diseases and disorders in the patients. Respiratory diagnostics are effective since it can diagnose the diseases at an early stage. It involve procedures such as computed tomography, spirometry, oximetry, chest X- ray, transcutaneous carbon dioxide monitoring, sniff nasal inspiratory pressure (SNIP) among several other types.

Middle East and Africa Respiratory Diagnostics Market Dynamics

Drivers

• Growing Rate of Pneumonia

The increasing prevalence of pneumonia is driving the market growth at a fast pace. Pneumonia is the top cause of morbidity and death in under-five children. It was expected that pneumonia kills around 900,000 under-five children each year globally. Around 172 deaths per 1,000 live births occur in sub-Saharan African countries, with pneumonia being the major cause. Thus, this increasing prevalence demands increased diagnostics which boost the market growth.

• Higher Demand of Hospitals

The growing demand of hospitals helps in increasing the market growth rapidly. Most respiratory disease diagnostics are primarily carried out in hospitals since they are very complex in nature and it requires technologically advanced products and therefore this is boosting the market for hospital or clinical laboratories. Thus, this factor boosts the market growth.

Opportunities

• Increased Elderly Population

The growing number of ageing population and their associated comorbid conditions such as deteriorating respiratory conditions, cough issues, community-acquired pneumonia, nonpneumonic respiratory tract infection and acute exacerbation of chronic obstructive pulmonary disease tend to create opportunities for the wide use of these diagnostics. It has been witnessed in the study of the IDF Diabetes Atlas, 10th edition, published in 2021, an expected 24 million adults aged 20-79 years were living with diabetes in the Africa region, having a regional prevalence of 4.5%. Furthermore, around 54% of people living with diabetes in the region are left undiagnosed. Thus, all these factors boost the market growth.

• Growing Product Launches and Collaborations

Numerous product launches, partnership and agreement are initiated by many companies globally, which are also increasing the respiratory diagnostics market. For instance, Abbott launched Panbio COVID-19 Rapid Test in France in September 2020 for supporting the detection of rapidly increasing COVID-19 patients in France. The company became in higher demand after the launch of this diagnostic test. Thus, these kinds of launches associated with the respiratory diagnostics boost the market growth.

Restraints/Challenges

• High Cost of Diagnostic Instruments

The increased expenditure required for the installation of these instruments hamper the market growth. Many of the diagnostic equipment are very high in cost, becoming unaffordable for many underdeveloped countries. Numerous market players make huge investments in installing new and advanced machines to increase the process and in return the cost is increased. Thus, this factor hamper the market growth.

This Middle East and Africa respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East and Africa Respiratory Diagnostics Market Scope

The Middle East and Africa respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

• Instruments and Devices
• Assays and Reagents
• Services and Software

Test Type

• Traditional Diagnostic Tests
• Mechanical Tests
• Imaging Tests
• Molecular Diagnostic Tests

Diseases

• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Asthma
• Tuberculosis
• Bronchitis
• Pulmonary Fibrosis
• Other Diseases

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

 Middle East and Africa Respiratory Diagnostics Market Regional Analysis/Insights

The Middle East and Africa respiratory diagnostics market is analyzed and market size insights and trends are provided by product and services, test type, diseases, end-user and distribution channel as referenced above.

呼吸诊断市场报告涉及的主要国家 是沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区。

沙特阿拉伯正引领市场增长，因为人们越来越关注老年人口中疾病的高发性。社交媒体的日益关注也是市场增长的主要因素。此外，一些公司正在利用新技术改进其诊断产品，以获得针对性强且准确的结果，从而推动该地区的增长。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

呼吸诊断还为您提供每个国家/地区资本设备医疗支出增长、呼吸诊断市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对呼吸诊断市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和中东和非洲呼吸诊断市场份额分析

呼吸诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对中东和非洲呼吸诊断市场的关注有关。

中东和非洲呼吸诊断市场的主要参与者包括：

• BD（美国）
• COSMED srl（意大利）
• 雅培（美国）
• 日本光电株式会社（日本）
• Drägerwerk AG & Co. KGaA（德国）
• Bio-Rad Laboratories, Inc.（美国）
• 赛默飞世尔科技公司（美国）
• 通用电气公司（美国）
• Koninklijke Philips NV（荷兰）
• 美敦力（爱尔兰）
• F. Hoffmann-La Roche Ltd（瑞士）
• MGC Diagnostics Corporation（美国）
• Masimo（美国）
• 生物梅里埃公司（法国）
• Carestream Health（美国）
• VYAIRE（美国）
• Seegene Inc.（韩国）
• ResMed（美国）

SKU-57099